Drug-resistant tuberculosis (DR-TB) poses a major threat, but next-generation sequencing (NGS) offers a powerful solution. In this video, leading tuberculosis (TB) experts discuss how Next-Generation Sequencing (NGS) is transforming surveillance, research, diagnostics, and ultimately, patient outcomes.​Featured experts: ​• Prof. Dr. Stefan Niemann, Research Center Borstel Leibniz Lung Center, Germany ​• Dr. Ameeta Joshi, Grant Medical College, India ​• Dr. Melanie Grobbelaar, Stellenbosch University, South Africa​• Dr. Philip Supply, Senior Scientist and Research Director, French National Center for Scientific Research (CNRS) and Institute Pasteur De Lille, France​• Ms. Anita Suresh, Deputy Director, Head of Genomics and Sequencing Unit, Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland ​• Dr. Saurabh Rane, Antimicrobial Resistance Fighter Coalition, India​Learn More: labroots.com/ms/webinar/transforming-dr-tb-detection-tngs-evidence-cost-analysis-implementation-considerations?campaign=TB_KOL_Video_Youtube #tuberculosis #drugresistance #NGS #WorldTBDay #YesWeCanEndTB #EndTB​Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: facebook.com/illuminainc LinkedIn: linkedin.com/company/illumina Instagram: instagram.com/illuminainc Twitter: twitter.com/illumina